Pioglitazone Promotes Survival and Prevents Hepatic Regeneration Failure After Partial Hepatectomy in Obese and Diabetic KK-Ay Mice

被引:49
作者
Aoyama, Tomonori [2 ]
Ikejima, Kenichi [1 ,2 ]
Kon, Kazuyoshi
Okumura, Kyoko
Arai, Kumiko
Watanabe, Sumio [2 ]
机构
[1] Juntendo Univ, Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Juntendo Univ, Grad Sch Med, Sportol Ctr, Tokyo 1138421, Japan
关键词
FATTY LIVER-DISEASE; ACTIVATED-RECEPTOR-GAMMA; STELLATE CELL ACTIVATION; 130-DEPENDENT PATHWAYS; CARBON-TETRACHLORIDE; INJURY; ALPHA; RAT; FIBROGENESIS; STEATOHEPATITIS;
D O I
10.1002/hep.22828
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Pathogenesis of metabolic syndrome-related nonalcoholic steatohepatitis (NASH) involves abnormal tissue-repairing responses in the liver. We investigated the effect of pioglitazone, a thiazolidinedione derivative (TZD), on hepatic regenerative responses in obese, diabetic KK-A(y) mice. Male KK-A(y) mice 9 weeks after birth underwent two-thirds partial hepatectomy (PH) after repeated intragastric injections of pioglitazone (25 mg/kg) for 5 days. Almost half of the KK-A(y) mice died within 48 hours of PH; however, mortality was completely prevented in mice pretreated with pioglitazone. In KK-A(y) mice, bromodeoxyuidine (BrdU) incorporation to hepatocyte nuclei 48 hours after PH reached only 1%; however, pioglitazone pretreatment significantly increased BrdU-positive cells to 8%. Cyclin D1 was barely detectable in KK-A(y) mice within 48 hours after PH. In contrast, overt expression of cyclin D1 was observed 24 hours after PH in KK-A(y) mice pretreated with pioglitazone. Hepatic tumor necrosis factor alpha (TNF-alpha) messenger RNA (mRNA) was tremendously increased 1 hour after PH in KK-A(y) mice, the levels reaching ninefold over C57B1/6 given PH, whereas pioglitazone blunted this increase by almost three-fourths. Pioglitazone normalized hypoadiponectinemia in KK-A(y) mice almost completely. Serum interleukin (IL)-6 and leptin levels were elevated extensively 24 hours after PH in KK-A(y) mice, whereas the levels were largely decreased in KK-A(y) mice given pioglitazone. Indeed, pioglitazone prevented aberrant increases in signal transducers and activators of transcription (STAT)3 phosphorylation and suppressor of cytokine signaling (SOCS)-3 mRNA in the liver in KK-A(y) mice. Conclusion: These findings indicated that pioglitazone improved hepatic regeneration failure in KK-A(y) mice. The mechanism underlying the effect of pioglitazone on regeneration failure most likely involves normalization of expression pattern of adipokines and subsequent cytokine responses during the early stage of PH. (HEPATOLOGY 2009; 49:1636-1644.)
引用
收藏
页码:1636 / 1644
页数:9
相关论文
共 39 条
  • [1] Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat
    Abe, Wataru
    Ikejima, Kenichi
    Lang, Tie
    Okumura, Kyoko
    Enomoto, Nobuyuki
    Kitamura, Tsuneo
    Takei, Yoshiyuki
    Sato, Nobuhiro
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 (02) : 286 - 294
  • [2] ANTIBODIES TO TUMOR-NECROSIS-FACTOR-ALPHA INHIBIT LIVER-REGENERATION AFTER PARTIAL-HEPATECTOMY
    AKERMAN, P
    COTE, P
    YANG, SQ
    MCCLAIN, C
    NELSON, S
    BAGBY, GJ
    DIEHL, AM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (04): : G579 - G585
  • [3] Nonalcoholic fatty liver disease
    Brunt, Elizabeth M.
    Wong, Vincent W. -S.
    Nobili, Valerio
    Day, Christopher P.
    Sookoian, Silvia
    Maher, Jacquelyn J.
    Bugianesi, Elisabetta
    Sirlin, Claude B.
    Neuschwander-Tetri, BrentA.
    Rinella, Mary E.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [4] A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
    Belfort, Renata
    Harrison, Stephen A.
    Brown, Kenneth
    Darland, Celia
    Finch, Joan
    Hardies, Jean
    Balas, Bogdan
    Gastaldelli, Amalia
    Tio, Fermin
    Pulcini, Joseph
    Berria, Rachele
    Ma, Jennie Z.
    Dwivedi, Sunil
    Havranek, Russell
    Fincke, Chris
    DeFronzo, Ralph
    Bannayan, George A.
    Schenker, Steven
    Cusi, Kenneth
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) : 2297 - 2307
  • [5] Nonalcoholic fatty liver disease
    Clark, JM
    Brancati, FL
    Diehl, AM
    [J]. GASTROENTEROLOGY, 2002, 122 (06) : 1649 - 1657
  • [6] Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice
    Cressman, DE
    Greenbaum, LE
    DeAngelis, RA
    Ciliberto, G
    Furth, EE
    Poli, V
    Taub, R
    [J]. SCIENCE, 1996, 274 (5291) : 1379 - 1383
  • [7] DIEHL AM, 1995, HEPATOLOGY, V22, P252, DOI 10.1016/0270-9139(95)90379-8
  • [8] Molecular dissection of gp 130-dependent pathways in hepatocytes during liver regeneration
    Dierssen, Uta
    Beraza, Naiara
    Lutz, Holger H.
    Liedtke, Christian
    Ernst, Matthias
    Wasmuth, Hermann E.
    Trautwein, Christian
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (15) : 9886 - 9895
  • [9] Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-γ, pioglitazone
    Enomoto, N
    Takei, Y
    Hirose, M
    Konno, A
    Shibuya, T
    Matsuyama, S
    Suzuki, S
    Ikejima, K
    Kitamura, T
    Sato, N
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (03) : 846 - 854
  • [10] Liver regeneration
    Fausto, N
    Campbell, JS
    Riehle, KJ
    [J]. HEPATOLOGY, 2006, 43 (02) : S45 - S53